Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wan-Long Chuang

Showing results (171-180 of 456) with videos related to

Pageof 46
Sort By:
Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 7, 2019
Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basisJee-Fu Huang, Pei-Chien Tsai, Ming-Lun Yeh, et al.
Plos One|January 29, 2021
The performance of HCV GT plus RUO reagent in determining Hepatitis C virus genotypes in TaiwanYing-Chou Huang, Chung-Feng Huang, Shu-Fen Liu, et al.
The Kaohsiung Journal of Medical Sciences|February 9, 2012
Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patientsMing-Yen Hsieh, Chia-Yen Dai, Li-Po Lee, et al.
The Kaohsiung Journal of Medical Sciences|April 30, 2020
Primary cultures of aspiration residual specimens predict outcomes of hepatocellular carcinoma patients receiving curative treatmentZu-Yau Lin, Jing-Houng Wang, Ming-Lun Yeh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2016
Time-Degenerative Factors and the Risk of Hepatocellular Carcinoma after Antiviral Therapy among Hepatitis C Virus Patients: A Model for Prioritization of TreatmentMing-Lung Yu, Chung-Feng Huang, Ming-Lun Yeh, et al.
Scientific Reports|October 27, 2018
Lower protein expression levels of MHC class I chain-related gene A in hepatocellular carcinoma are at high risk of recurrence after surgical resectionChung-Feng Huang, Shu-Chi Wang, Wen-Tsan Chang, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 30, 2006
Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapyMing-Lung Yu, Wan-Long Chuang, Chia-Yen Dai, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 30, 2006
Polymorphism of interferon-gamma gene at position +874 and clinical characteristics of chronic hepatitis CChia-Yen Dai, Wan-Long Chuang, Ming-Yen Hsieh, et al.
Antiviral Therapy|February 17, 2007
Outcome of chronic hepatitis C patients who required early termination of pegylated interferon-alpha plus ribavirin combination therapyMing-Lung Yu, Chia-Yen Dai, Li-Po Lee, et al.
Journal of Gastroenterology and Hepatology|March 23, 2007
Comparison of liver histopathology between chronic hepatitis C patients and chronic hepatitis B and C-coinfected patientsLi-Po Lee, Chia-Yen Dai, Wan-Long Chuang, et al.
Pageof 46

Showing results (171-180 of 456) with videos related to

Sort By:
Pageof 46
Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 7, 2019
Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basisJee-Fu Huang, Pei-Chien Tsai, Ming-Lun Yeh, et al.
Plos One|January 29, 2021
The performance of HCV GT plus RUO reagent in determining Hepatitis C virus genotypes in TaiwanYing-Chou Huang, Chung-Feng Huang, Shu-Fen Liu, et al.
The Kaohsiung Journal of Medical Sciences|February 9, 2012
Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patientsMing-Yen Hsieh, Chia-Yen Dai, Li-Po Lee, et al.
The Kaohsiung Journal of Medical Sciences|April 30, 2020
Primary cultures of aspiration residual specimens predict outcomes of hepatocellular carcinoma patients receiving curative treatmentZu-Yau Lin, Jing-Houng Wang, Ming-Lun Yeh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2016
Time-Degenerative Factors and the Risk of Hepatocellular Carcinoma after Antiviral Therapy among Hepatitis C Virus Patients: A Model for Prioritization of TreatmentMing-Lung Yu, Chung-Feng Huang, Ming-Lun Yeh, et al.
Scientific Reports|October 27, 2018
Lower protein expression levels of MHC class I chain-related gene A in hepatocellular carcinoma are at high risk of recurrence after surgical resectionChung-Feng Huang, Shu-Chi Wang, Wen-Tsan Chang, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 30, 2006
Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapyMing-Lung Yu, Wan-Long Chuang, Chia-Yen Dai, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 30, 2006
Polymorphism of interferon-gamma gene at position +874 and clinical characteristics of chronic hepatitis CChia-Yen Dai, Wan-Long Chuang, Ming-Yen Hsieh, et al.
Antiviral Therapy|February 17, 2007
Outcome of chronic hepatitis C patients who required early termination of pegylated interferon-alpha plus ribavirin combination therapyMing-Lung Yu, Chia-Yen Dai, Li-Po Lee, et al.
Journal of Gastroenterology and Hepatology|March 23, 2007
Comparison of liver histopathology between chronic hepatitis C patients and chronic hepatitis B and C-coinfected patientsLi-Po Lee, Chia-Yen Dai, Wan-Long Chuang, et al.
Pageof 46